Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | LUCD Lucid Diagnostics Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $0.83 -1.4% | $14.86 -2.5% |
| StockIQ Score | 45D+ Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 42D | 13F |
| Fundamental | 23F | 35F |
| Growth | 48D+ | 50C- |
| Fair Value | 50C- | 38F |
| News | 80A- | 50C- |
| Quality | 58C | 50C- |
| Risk | 34F | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Lucid Diagnostics (LUCD) outperforms Ascentage Pharma (AAPG) in technical and valuation scores, with 9 versus 18 and 50 versus 38 respectively. AAPG leads in growth (50 vs. 48) and fundamental scores (35 vs. 23). Both share identical investor scores and weak ratings, but LUCD’s higher valuation and technical scores suggest stronger market sentiment in those areas.
